Skip to main content

Table 2 Logistic regression analysis on moderate to severe stage of fibrosis

From: FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B

  

Stage > =2 (n = 15) n (%) or Mean (SD)

Stage < 2 (n = 30) n (%) or Mean (SD)

  

Univariable logistic regression

Multivariable logistic regression***

Variable

 

OR

95% CI

p-value

p-value

Age

 

46.87 (13.93)

40.17 (10.72)

1.05

0.993; 1.110

0.089

 

Gender, N (%)

Male

11 (42.31)

15 (57.69)

2.75

0.713; 10.605

0.1418

0.0641

 

Female*

4 (21.05)

15 (78.95)

    

Race, N (%)

Caucasian*

1 (16.67)

5 (83.33)

  

0.2845

 
 

AA

9 (50.00)

9(50.00)

5

0.483; 51.769

  
 

Asian

4 (22.22)

14 (77.78)

1.429

0.127; 16.025

  
 

Other

1 (33.33)

2 (66.67)

2.5

0.1; 62.602

  

Diagnosis

HBV

7 (21.21)

26 (78.79)

0.135

0.031; 0.581

0.0072**

0.0156**

 

HIV/HBV*

8 (66.67)

4 (33.33)

    

Inflammation

Grade > 1

12 (57.14)

9 (42.86)

9.333

2.110; 41.278

0.0032**

0.0066**

 

Grade < =1*

3 (12.50)

21 (87.50)

    

FibroSURE

 

0.462 (0.297)

0.212 (0.167)

3.015§

1.426; 6.374

0.0039**

0.0158**

log10 ALT (U/L)

 

1.81 (0.25)

1.52 (0.28)

3.314§

1.393; 7.883

0.0067**

 

log10 AST (U/L)

 

1.70 (0.21)

1.51 (0.25)

2.455§

1.065; 5.658

0.0350**

 

log10 HBV DNA (IU/ml)

5.24 (2.98)

4.60 (2.39)

1.304§

0.674; 2.520

0.4303

 
  1. *Reference group for the reported odds ratios.
  2. **p-value < 0.05.
  3. ***Based on the best selected model.
  4. §OR of 1 SD increase.
  5. Abbreviations: ALT alanine aminotransferase, AST aspartate aminotransferase, HBV hepatitis B virus, SD standard deviation, OR odds ratio, CI confidence interval, AA African-American, HIV human immunodefiency virus.